ruxolitinib topical
Selected indexed studies
- Topical ruxolitinib: A new treatment for vitiligo. (J Eur Acad Dermatol Venereol, 2023) [PMID:37147856]
- Utilization of Topical Ruxolitinib in Dermatology: A Review. (Skin Therapy Lett, 2023) [PMID:37339609]
- Novel Clinical Applications of Topical Ruxolitinib: A Case Series. (J Drugs Dermatol, 2024) [PMID:38443119]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo. (2024) pubmed
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. (2023) pubmed
- Topical ruxolitinib: A new treatment for vitiligo. (2023) pubmed
- Utilization of Topical Ruxolitinib in Dermatology: A Review. (2023) pubmed
- Novel Clinical Applications of Topical Ruxolitinib: A Case Series. (2024) pubmed
- Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives. (2025) pubmed
- Topical Ruxolitinib and Delgocitinib Versus Systemic JAK Inhibitors: A Comparative Safety Review. (2025) pubmed
- Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. (2022) pubmed
- A Review on the Use of Topical Ruxolitinib for the Treatment of Vitiligo. (2023) pubmed
- New Non-Steroidal Topical Therapies for Inflammatory Dermatoses-Part 1: Ruxolitinib. (2023) pubmed